MedPage Today on MSN
Time of Day Matters for Immunochemotherapy in Lung Cancer
This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...
Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...
Sabari — editor-in-chief of CURE, assistant professor at NYU Grossman School of Medicine, and director of High Reliability Organization Initiatives at Perlmutter Cancer Center — discussed how various ...
Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
The guidelines were formally released by Union Health and Family Welfare Minister Jagat Prakash Nadda at Kartavya Bhavan in ...
When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...
A 55 year-old struck with 'incurable' stage 4 lung cancer six years ago that spread to his brain has miraculously seen the ...
Some experts are calling for universal lung cancer screening.
There are plans for earlier diagnosis and faster treatment in England but experts worry about lack of staff.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results